-
H.I.G. Supports MedPro
Post on 7/11/19
-
Clearside Biomedical Announces License Agreement with Aura Biosciences
Post on 7/9/19
-
CSI Laboratories Announces Equity Stake Acquisition by Synergy Capital Investments
Post on 7/9/19
-
UnitedHealth Group Announces Atlanta HBCU Partnership, $8.25 Million Investment in the Education of Future Data Scientists
Post on 7/2/19
-
Children’s Community Health Plan Renews Relationship with Cotiviti
Post on 6/27/19
-
AdhereHealth And Papa Partner to Tackle Barriers of Care
Post on 6/25/19
-
Advanced 3D X-ray System Receives Oral Healthcare Industry’s Highest Honor
Post on 6/20/19
-
National Spine and Pain Centers Expands Its Services to Practices in Georgia and Illinois
Post on 6/13/19
-
Galectin Therapeutics Raises $44.5 Million in Rights Offering
Post on 5/28/19
-
LogistiCare and National Kidney Foundation Partner
Post on 5/20/19
-
Haemonetics To Transfer Union, South Carolina, Manufacturing Facility To CSL Plasma
Post on 5/14/19
-
Premier to Exit Specialty Pharmacy Business
Post on 5/6/19
-
2019’s Best & Worst States for Children’s Health Care – WalletHub Study
Post on 4/17/19
-
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Post on 4/11/19
-
QUE Oncology Launches Phase II Trials in the United States
Post on 4/3/19
-
2019’s Best & Worst States for Doctors – WalletHub Study
Post on 3/25/19
-
New Study: Reusable Bronchoscopes Cost More Than Sterile Single-use Bronchoscopes
Post on 3/19/19
-
PharmMD Changes Company Name to AdhereHealth
Post on 3/14/19
-
Stevens & Wilkinson Reveals Plans for Three New State Veterans Nursing Homes
Post on 3/13/19
-
Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor
Post on 3/12/19
-
Henry Schein Completes Acquisition Of North American Rescue
Post on 3/4/19
-
CareDox and PowerSchool Announce Partnership
Post on 2/21/19
-
Quest Diagnostics Partners With Houston Healthcare
Post on 2/20/19
-
Spine Pain Center Partners with Revitalize Health
Post on 2/18/19
-
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia
Post on 2/7/19